US 8609650
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted A61PA61P13/12A61P17/06
Quick answer
US patent 8609650 (Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P13/12, A61P17/06, A61P19/00, A61P19/02